Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;25(1):84-92.
doi: 10.1016/j.jfda.2016.10.017. Epub 2016 Dec 5.

Polyphenols with antiglycation activity and mechanisms of action: A review of recent findings

Affiliations
Review

Polyphenols with antiglycation activity and mechanisms of action: A review of recent findings

Wan-Ju Yeh et al. J Food Drug Anal. 2017 Jan.

Abstract

Advanced glycation end products (AGEs) are substances composed of amino groups of proteins and reducing sugars. The initial and propagation phases of the glycation process are accompanied by the production of a large amount of free radicals, carbonyl species, and reactive dicarbonyl species, of which, methylglyoxal (MG) is the most reactive and can cause dicarbonyl stress, influencing normal physiological functions. In the advanced phase, the production of AGEs and the interaction between AGEs and their receptor, RAGE, are also considered to be among the causes of chronic diseases, oxidative stress, and inflammatory reaction. Till date, multiple physiological activities of polyphenols have been confirmed. Recently, there have been many studies discussing the ability of polyphenols to suppress the MG and AGEs formation, which was also confirmed in some in vivo studies. This review article collects recent literatures concerning the effects of polyphenols on the generation of MG and AGEs through different pathways and discusses the feasibility of the inhibition of glycative stress and dicarbonyl stress by polyphenols.

Keywords: advanced glycation end products; antiglycation; flavonoid; phenolic acid; polyphenols.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Pathway for AGE formation. The N-terminal amino groups of protein and reducing sugar form dicarbonyls including methylglyoxal, glyoxal, and 3-deoxyglucosone through polyol pathway, glycolysis, or autoxidation of reducing sugar, leading to generation of pathological AGEs. AGE=advanced glycation end product; CEL=N ɛ-carboxyethyllysine; CML=N ɛ-carboxymethyllysine; 3-dG=3-deoxyglucosone; DOLD=3-deoxyglucosone lysine dimer; GO=glyoxal; GOLD=glyoxal-lysine dimer; MG=methylglyoxal; MGH =MG-derived-hydroimidazalone; MOLD=methylglyoxal-lysine dimer.
Figure 2
Figure 2
Chemical structures of MG-derived AGEs. AGE=advanced glycation end product; CEL=N ɛ-carboxyethyllysine; MG=methylglyoxal; MG-H=MG-derived-hydroimidazalone; MODIC = imidazolium cross-link derived from methylglyoxal and lysine-arginine; MOLD=methylglyoxal-lysine dimer.
Figure 3
Figure 3
Glyoxalase system. The detoxification system of MG in all cells. GLO 1 plays a first step in catalyzing MG to s-D-Lactoylglutathione. It is a key enzyme in glyoxalase system for regulating the MG formation. MG=methylglyoxal; GLO = glyoxalase.
Figure 4
Figure 4
Antiglycation mechanisms of polyphenols. Several strategies are designed of AGE inhibitor. (1) Inhibition of ROS formation during glycation. (2) Inhibition of Schiff base, Amadori products, and subsequent dicarbonyl groups formation. (3) Detoxification of AGE precursor-MG by glyoxalase system. (4) Inhibition of harmful AGEs formation. (5) Blocking of AGE–RAGE interaction inhibits oxidative stress and ROS generation, inflammatory stimuli, and physical injury through different pathways. AGE=advanced glycation end product; GLO=glyoxalase; MG=methylglyoxal; RAGE=receptor of AGEs; ROS=reactive oxygen species.

Similar articles

Cited by

References

    1. Maillard LC. Formation of Melanoidins in a Methodical Way. Compt Rend. 1912;154:66–8.
    1. Peppa M, Vlassara H. Advanced glycation end products and diabetic complications: a general overview. Hormones (Athens) 2005;4:28–37. - PubMed
    1. Yeh WJ, Yang HY, Pai MH, Wu CH, Chen JR. Long-term administration of advanced glycation end product stimulates the activation of NLRP3 inflammasome and sparking the development of renal injury. J Nutr Biochem. 2016;39:68–76. - PubMed
    1. Lin JA, Wu CH, Lu CC, Hsia SM, Yen GC. Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression. Mol Nutr Food Res. 2016;60:1850–64. - PubMed
    1. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129–46. - PubMed

LinkOut - more resources